Erkut Attar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Erkut Attar has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Melis Gokce Kocer Yazici
Reproductive Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Yeditepe University, 34752 Istanbul, Türkiye
2 shared publications - Ozlem Dural
Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
2 shared publications - Rukset Attar
Reproductive Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Yeditepe University, 34752 Istanbul, Türkiye
2 shared publications - Zeynep Ece Utkan Korun
Department of Obstetrics and Gynecology, Faculty of Medicine, Yeditepe University, 34755 Ataşehir, Istanbul, Turkey
2 shared publications - Ahmet Ozturk
Department of Stem Cell and Tissue Regeneration, Institute of Health Sciences, Kocaeli University, Kocaeli, Türkiye
1 shared publication - Aslı Nehir Aytan
Bahcesehir Univ, Dept Obstet & Gynecol, Fac Med, Istanbul, Turkey
1 shared publication
Latest Publications
- 23 July 2026
- Published by Wiley in Clinical Endocrinology
- Vol. 105 (4) , 493-504
Reassessing the Luteinizing Hormone/Follicle‐Stimulating Hormone Ratio in Polycystic Ovary Syndrome: Associations With a Possible Neuroendocrine and Anti‐Müllerian Hormone‐Related Phenotype
Purpose: To comprehensively reassess the clinical and metabolic significance of the luteinizing hormone (LH) to follicle‐stimulating hormone (FSH) ratio in women with polycystic ovary syndrome (PCOS), and to investigate whether it is associated with a clinical and hormonal pattern consistent with a possible neuroendocrine‐dominant subgroup, distinguishable from insulin‐related metabolic presentation. Design: Observational cross‐sectional study. Methods: This retrospective cross‐sectional study included 316 women diagnosed with PCOS according to the Rotterdam criteria at a tertiary university hospital. Patients were categorised based on their LH:FSH ratio (using a cut‐off of 2) and their PCOS phenotypes (Phenotypes A, B, C, and D). Clinical, hormonal, and metabolic parameters, including anti‐Müllerian hormone (AMH) levels and ovarian volume, were compared across groups. Results: Among 316 patients, 18.35% had an LH:FSH ratio >2. A strong positive correlation was found between LH:FSH ratio and AMH levels ( r = 0.65, p < 0.001), and a significant correlation was observed with ovarian volume ( r = 0.20, p = 0.001) and polycystic ovarian morphology (mean LH:FSH 1.59 vs. 1.15, p < 0.001). Patients with phenotype D (OA + PCOM, non‐hyperandrogenic PCOS) exhibited the highest LH:FSH ratio (1.75 ± 0.87). Higher LH:FSH ratios were associated with oligo/amenorrhea (1.59 vs. 1.22, p < 0.001), anovulation (1.66 vs. 1.16, p < 0.001), and lower midluteal progesterone (ρ = −0.28, p < 0.001), but not with serum androgens or Ferriman‐Gallwey scores. Weak positive correlations were observed with insulin levels (ρ = 0.18, p = 0.022) and HOMA‐IR (ρ = 0.18, p = 0.021), but no significant associations were found with BMI, glucose tolerance, or lipid profile. Conclusion: A high LH:FSH ratio is associated with a clinical and hormonal pattern—including elevated AMH levels, prominent PCOM, and anovulation—that may be consistent with a neuroendocrine‐dominant presentation of PCOS, rather than metabolic or androgenic disturbances. If confirmed by prospective studies, this association could inform more individualised therapeutic approaches.
- 23 July 2026
- Published by Wiley in Clinical Endocrinology
- Vol. 105 (4) , 493-504
Reassessing the Luteinizing Hormone/Follicle‐Stimulating Hormone Ratio in Polycystic Ovary Syndrome: Associations With a Possible Neuroendocrine and Anti‐Müllerian Hormone‐Related Phenotype
Purpose: To comprehensively reassess the clinical and metabolic significance of the luteinizing hormone (LH) to follicle‐stimulating hormone (FSH) ratio in women with polycystic ovary syndrome (PCOS), and to investigate whether it is associated with a clinical and hormonal pattern consistent with a possible neuroendocrine‐dominant subgroup, distinguishable from insulin‐related metabolic presentation. Design: Observational cross‐sectional study. Methods: This retrospective cross‐sectional study included 316 women diagnosed with PCOS according to the Rotterdam criteria at a tertiary university hospital. Patients were categorised based on their LH:FSH ratio (using a cut‐off of 2) and their PCOS phenotypes (Phenotypes A, B, C, and D). Clinical, hormonal, and metabolic parameters, including anti‐Müllerian hormone (AMH) levels and ovarian volume, were compared across groups. Results: Among 316 patients, 18.35% had an LH:FSH ratio >2. A strong positive correlation was found between LH:FSH ratio and AMH levels ( r = 0.65, p < 0.001), and a significant correlation was observed with ovarian volume ( r = 0.20, p = 0.001) and polycystic ovarian morphology (mean LH:FSH 1.59 vs. 1.15, p < 0.001). Patients with phenotype D (OA + PCOM, non‐hyperandrogenic PCOS) exhibited the highest LH:FSH ratio (1.75 ± 0.87). Higher LH:FSH ratios were associated with oligo/amenorrhea (1.59 vs. 1.22, p < 0.001), anovulation (1.66 vs. 1.16, p < 0.001), and lower midluteal progesterone (ρ = −0.28, p < 0.001), but not with serum androgens or Ferriman‐Gallwey scores. Weak positive correlations were observed with insulin levels (ρ = 0.18, p = 0.022) and HOMA‐IR (ρ = 0.18, p = 0.021), but no significant associations were found with BMI, glucose tolerance, or lipid profile. Conclusion: A high LH:FSH ratio is associated with a clinical and hormonal pattern—including elevated AMH levels, prominent PCOM, and anovulation—that may be consistent with a neuroendocrine‐dominant presentation of PCOS, rather than metabolic or androgenic disturbances. If confirmed by prospective studies, this association could inform more individualised therapeutic approaches.
- 22 July 2026
- Published by Springer Nature in Reproductive Sciences
- Vol. 33 (9) , 1687-1699
Smartphone-Assisted CSCTAS-Derived Sperm Kinematics and Clinical Pregnancy after Intrauterine Insemination in a Turkish Cohort of Couples with Unexplained Infertility
- 22 July 2026
- Published by Springer Nature in Reproductive Sciences
- Vol. 33 (9) , 1687-1699
Smartphone-Assisted CSCTAS-Derived Sperm Kinematics and Clinical Pregnancy after Intrauterine Insemination in a Turkish Cohort of Couples with Unexplained Infertility
- 9 June 2026
- Published by Academician Publishing
- p. 561-568
GnRH’a ve GnRH Antagonistlerin Etki Mekanizmaları
- 9 June 2026
- Published by Academician Publishing
- p. 561-568
GnRH’a ve GnRH Antagonistlerin Etki Mekanizmaları
- 9 June 2026
- Published by Academician Publishing
- p. 347-352
Endometrial Siklus ve Reseptivite
- Open Access
- 27 October 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-16
Quercetin-loaded mesenchymal stem cell derived extracellular vesicles enhance ovarian function in a cyclophosphamide induced ovarian damage
Background: To investigate whether intraovarian administration of quercetin-loaded extracellular vesicles derived from Wharton’s jelly mesenchymal stem cells (EVs-QUE) improves ovarian function in a cyclophosphamide (CTX)-induced premature ovarian insufficiency (POI) rat model. Methods: Human Wharton’s jelly-derived mesenchymal stem cells (MSCs) were cultured, and extracellular vesicles (EVs) were isolated and characterized by flow cytometry and electron microscopy. Quercetin was loaded onto EVs using ultrasonic incubation to generate EVs-QUE. A rat model of CTX-induced POI was established, and the subjects received intraovarian injections of either EVs or EVs-QUE. Ovarian function was assessed through histological evaluation, immunofluorescence staining, and gene expression analysis. Results: Treatment with EVs-QUE significantly improved ovarian morphology and folliculogenesis, reduced the number of atretic follicles, and decreased Casp3 expression. Proliferation markers ( Ki67 , Pcna ) and antioxidant genes ( Nrf2 , Sod1 ) were upregulated. Additionally, steroidogenesis- and oocyte-related genes ( Star , Gdf9 , Bmp15 ) showed increased expression. Although systemic hormonal alterations were limited, local tissue analysis confirmed a regenerative effect in the EVs-QUE group. Conclusions: Quercetin-loaded EVs derived from Wharton’s jelly MSCs enhanced ovarian recovery in a CTX-induced POI model through anti-apoptotic, pro-proliferative, and antioxidant pathways. These findings suggest that intraovarian administration of EVs-QUE may represent a promising strategy for fertility preservation and warrant further investigation in long-term and translational studies.
- 27 October 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-16
Open AccessQuercetin-loaded mesenchymal stem cell derived extracellular vesicles enhance ovarian function in a cyclophosphamide induced ovarian damage
Background: To investigate whether intraovarian administration of quercetin-loaded extracellular vesicles derived from Wharton’s jelly mesenchymal stem cells (EVs-QUE) improves ovarian function in a cyclophosphamide (CTX)-induced premature ovarian insufficiency (POI) rat model. Methods: Human Wharton’s jelly-derived mesenchymal stem cells (MSCs) were cultured, and extracellular vesicles (EVs) were isolated and characterized by flow cytometry and electron microscopy. Quercetin was loaded onto EVs using ultrasonic incubation to generate EVs-QUE. A rat model of CTX-induced POI was established, and the subjects received intraovarian injections of either EVs or EVs-QUE. Ovarian function was assessed through histological evaluation, immunofluorescence staining, and gene expression analysis. Results: Treatment with EVs-QUE significantly improved ovarian morphology and folliculogenesis, reduced the number of atretic follicles, and decreased Casp3 expression. Proliferation markers ( Ki67 , Pcna ) and antioxidant genes ( Nrf2 , Sod1 ) were upregulated. Additionally, steroidogenesis- and oocyte-related genes ( Star , Gdf9 , Bmp15 ) showed increased expression. Although systemic hormonal alterations were limited, local tissue analysis confirmed a regenerative effect in the EVs-QUE group. Conclusions: Quercetin-loaded EVs derived from Wharton’s jelly MSCs enhanced ovarian recovery in a CTX-induced POI model through anti-apoptotic, pro-proliferative, and antioxidant pathways. These findings suggest that intraovarian administration of EVs-QUE may represent a promising strategy for fertility preservation and warrant further investigation in long-term and translational studies.
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF BIOLOGY
- Vol. 46 (5) , 400-413
The investigation of diverse physiological and therapeutic impact of cellular-based products derived from human cumulus cells
Particular somatic cells, namely cumulus cells (CCs) that support the oocyte maturation, fertility, and viability by providing the nutrients and energy to the oocyte envelop the mammalian oocyte. In this study, discarded human cumulus tissues were used to reveal the value of hyaluronic acid-rich CCs on several cellular events, including differentiation. Conditioned media, recovered from the primary culture of CCs, were introduced to the human nucleus pulposus cells (hNPCs) which were functionally distorted because of the loss of chondrogenecity. Enlightening the impact of cumulus conditioned media (CCM) on wound healing and angiogenesis was also investigated. In line with these goals, differentiation of hNPCs into chondrocytes with CCM as the basal medium containing traditional differentiation agents was induced upon isolation and characterization of hCCs and hNPCs. The effects were detected by differentiation-specific cell stains and gene expression analyses. Scratch and tube formation assays were performed to detect the effect of CCM on wound healing and angiogenesis. Our results showed that cumulus cell-conditioned media promoted the chondrogenesis and osteogenesis of hNPCs. A significant increase in angiogenesis and ability for wound closure was detected only in groups cultured in CCM compared to the control. These findings demonstrated that CCM might be used in therapeutics.
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF BIOLOGY
- Vol. 46 (5) , 400-413
Open AccessThe investigation of diverse physiological and therapeutic impact of cellular-based products derived from human cumulus cells
Particular somatic cells, namely cumulus cells (CCs) that support the oocyte maturation, fertility, and viability by providing the nutrients and energy to the oocyte envelop the mammalian oocyte. In this study, discarded human cumulus tissues were used to reveal the value of hyaluronic acid-rich CCs on several cellular events, including differentiation. Conditioned media, recovered from the primary culture of CCs, were introduced to the human nucleus pulposus cells (hNPCs) which were functionally distorted because of the loss of chondrogenecity. Enlightening the impact of cumulus conditioned media (CCM) on wound healing and angiogenesis was also investigated. In line with these goals, differentiation of hNPCs into chondrocytes with CCM as the basal medium containing traditional differentiation agents was induced upon isolation and characterization of hCCs and hNPCs. The effects were detected by differentiation-specific cell stains and gene expression analyses. Scratch and tube formation assays were performed to detect the effect of CCM on wound healing and angiogenesis. Our results showed that cumulus cell-conditioned media promoted the chondrogenesis and osteogenesis of hNPCs. A significant increase in angiogenesis and ability for wound closure was detected only in groups cultured in CCM compared to the control. These findings demonstrated that CCM might be used in therapeutics.
- 17 January 2021
- Published by H1 Connect
Faculty Opinions recommendation of Targeting DNA Methylation Depletes Uterine Leiomyoma Stem Cell-enriched Population by Stimulating Their Differentiation.
Uterine leiomyomas (LMs) are the most common tumors in women. They can cause severe morbidity. Treatment of LMs is individualized based on the severity of the symptoms, the size and location of the leiomyoma lesions, the patient’s age and their chronological proximity to menopause, and the patient’s desire for future fertility. The gold standard of leiomyoma treatment is surgery. Hysterectomy is the definitive surgical operation, but myomectomy is still commonly performed especially in women who desire future fertility. More recently developed techniques, which include uterine artery embolization (UAE), magnetic resonance-guided focused ultrasound surgery (MRgFUS), and myolysis, are emerging as minimally invasive alternative procedures. LMs tend to recur in different parts of the uterus. There are no definitive therapeutic agents for the treatment of uterine LMs. Therefore, there is a need for new treatments. Understanding the molecular mechanisms which are involved in the development of these tumors is very important for developing new treatment modalities. This study is an important study as it addresses an important molecular mechanism in the development of LMs. It is known that LM growth requires the maintenance and proliferation of a stem cell population. Dysregulated deoxyribonucleic acid (DNA) methylation has been reported in LM, but its role in LM stem cell regulation remains unclear. In this study, the authors have investigated the effect of DNA methylation in LMs. They have observed an inverse relationship between methylation and gene expression changes during LSC differentiation. In LSC, hypermethylation suppressed the genes important for myometrium- and LM-associated functions, including muscle contraction and hormone action, to maintain stemness. They have shown that hypomethylating drug, 5'-Aza, stimulated LSC differentiation, depleting the stem cell population and inhibiting tumor initiation. Thus, they have suggested that DNA methylation maintains the pool of LSC, which is critical for the regeneration of LM tumors.
- 17 January 2021
- Published by H1 Connect
Faculty Opinions recommendation of Targeting DNA Methylation Depletes Uterine Leiomyoma Stem Cell-enriched Population by Stimulating Their Differentiation.
Uterine leiomyomas (LMs) are the most common tumors in women. They can cause severe morbidity. Treatment of LMs is individualized based on the severity of the symptoms, the size and location of the leiomyoma lesions, the patient’s age and their chronological proximity to menopause, and the patient’s desire for future fertility. The gold standard of leiomyoma treatment is surgery. Hysterectomy is the definitive surgical operation, but myomectomy is still commonly performed especially in women who desire future fertility. More recently developed techniques, which include uterine artery embolization (UAE), magnetic resonance-guided focused ultrasound surgery (MRgFUS), and myolysis, are emerging as minimally invasive alternative procedures. LMs tend to recur in different parts of the uterus. There are no definitive therapeutic agents for the treatment of uterine LMs. Therefore, there is a need for new treatments. Understanding the molecular mechanisms which are involved in the development of these tumors is very important for developing new treatment modalities. This study is an important study as it addresses an important molecular mechanism in the development of LMs. It is known that LM growth requires the maintenance and proliferation of a stem cell population. Dysregulated deoxyribonucleic acid (DNA) methylation has been reported in LM, but its role in LM stem cell regulation remains unclear. In this study, the authors have investigated the effect of DNA methylation in LMs. They have observed an inverse relationship between methylation and gene expression changes during LSC differentiation. In LSC, hypermethylation suppressed the genes important for myometrium- and LM-associated functions, including muscle contraction and hormone action, to maintain stemness. They have shown that hypomethylating drug, 5'-Aza, stimulated LSC differentiation, depleting the stem cell population and inhibiting tumor initiation. Thus, they have suggested that DNA methylation maintains the pool of LSC, which is critical for the regeneration of LM tumors.
- 1 August 2020
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 36 (4) , 165-172
Enhanced Recovery Pathways in Gynecology
Objective: Enhanced recovery after surgery (ERAS) is a multimodal approach to improving outcomes surrounding perioperative care. Recommendations are regulation of intake fluids and foods, nausea, vomiting management and encouraging a regular diet, and early mobilization. In this article, ERAS rules and regulations for better perioperative outcome and comfort are discussed. Materials and Methods: This article discusses major reviews and recommendations of medical societies for ERAS. Results: Prompt removal of drains, catheters, and lines and using laxatives on routine basis are inevitable landmarks of ERAS protocol. Hypothermia, decreased perfusion of peripheral organs, fluid and electrolyte imbalances, and insulin resistance all can lead to the release of counter regulatory hormones, including cortisol, growth hormone, glucagon, and catecholamines. Hormonal changes around surgery can trigger the release of inflammatory cytokines that eventually may lead to adverse outcomes. Conclusions: The main goal of ERAS is to prevent and decrease this negative cascade in the context of perioperative care. (J GYNECOL SURG 36:165)
- 1 August 2020
- Published by SAGE Publications in Journal of Gynecologic Surgery
- Vol. 36 (4) , 165-172
Enhanced Recovery Pathways in Gynecology
Objective: Enhanced recovery after surgery (ERAS) is a multimodal approach to improving outcomes surrounding perioperative care. Recommendations are regulation of intake fluids and foods, nausea, vomiting management and encouraging a regular diet, and early mobilization. In this article, ERAS rules and regulations for better perioperative outcome and comfort are discussed. Materials and Methods: This article discusses major reviews and recommendations of medical societies for ERAS. Results: Prompt removal of drains, catheters, and lines and using laxatives on routine basis are inevitable landmarks of ERAS protocol. Hypothermia, decreased perfusion of peripheral organs, fluid and electrolyte imbalances, and insulin resistance all can lead to the release of counter regulatory hormones, including cortisol, growth hormone, glucagon, and catecholamines. Hormonal changes around surgery can trigger the release of inflammatory cytokines that eventually may lead to adverse outcomes. Conclusions: The main goal of ERAS is to prevent and decrease this negative cascade in the context of perioperative care. (J GYNECOL SURG 36:165)
- Open Access
- 8 January 2019
- Published by SAGE Publications in Journal of Endometriosis and Pelvic Pain Disorders
- Vol. 11 (1) , 19-24
Association between endometriosis, headache, and migraine
Introduction: Available data suggest that there is an association between endometriosis and a group of disorders including autonomic nervous system irregularities. A deeper understanding of relationship between endometriosis and autonomic nervous system is needed as it may lead to novel discoveries on the causes or consequences of endometriosis. In this study, we analyzed the prevalence of migraine in patients with endometriosis. Methods: In this cross-sectional study, medical records of women were reviewed through January 2013 to December 2017. Women with laparoscopically proven endometriosis (n = 185) were compared with those without endometriosis (n = 168). The 3-item screening questions (ID Migraine™) test was used to screen migraine. Data were analyzed using SPSS v25 (IBM Corporation). The χ2 test was used for analyzing the nominal parameters and group comparisons. Pearson χ2 was used to study the association between endometriosis and migraine. Results: The mean age was 31.86 ± 4.49 years of the endometriosis group and 28.95 ± 5.11 years of the controls (p = 0.408). The two pre-screening questions of ID Migraine test were answered positively by 86 patients of the endometriosis group (75.4%) and by 53 patients of the control group (54.6%) (p = 0.001). Of these patients, 51 (44.7% of endometriosis group) and 26 (26.8% of control group) were diagnosed as having migraine using 3-item Migraine questionnaire (p = 0.007). Conclusion: This study showed that the prevalence of migraine was significantly higher in patients with endometriosis. Because there is a strong correlation, patients with endometriosis should be screened for headache and migraine to increase the benefits of care.
- 8 January 2019
- Published by SAGE Publications in Journal of Endometriosis and Pelvic Pain Disorders
- Vol. 11 (1) , 19-24
Open AccessAssociation between endometriosis, headache, and migraine
Introduction: Available data suggest that there is an association between endometriosis and a group of disorders including autonomic nervous system irregularities. A deeper understanding of relationship between endometriosis and autonomic nervous system is needed as it may lead to novel discoveries on the causes or consequences of endometriosis. In this study, we analyzed the prevalence of migraine in patients with endometriosis. Methods: In this cross-sectional study, medical records of women were reviewed through January 2013 to December 2017. Women with laparoscopically proven endometriosis (n = 185) were compared with those without endometriosis (n = 168). The 3-item screening questions (ID Migraine™) test was used to screen migraine. Data were analyzed using SPSS v25 (IBM Corporation). The χ2 test was used for analyzing the nominal parameters and group comparisons. Pearson χ2 was used to study the association between endometriosis and migraine. Results: The mean age was 31.86 ± 4.49 years of the endometriosis group and 28.95 ± 5.11 years of the controls (p = 0.408). The two pre-screening questions of ID Migraine test were answered positively by 86 patients of the endometriosis group (75.4%) and by 53 patients of the control group (54.6%) (p = 0.001). Of these patients, 51 (44.7% of endometriosis group) and 26 (26.8% of control group) were diagnosed as having migraine using 3-item Migraine questionnaire (p = 0.007). Conclusion: This study showed that the prevalence of migraine was significantly higher in patients with endometriosis. Because there is a strong correlation, patients with endometriosis should be screened for headache and migraine to increase the benefits of care.
- 1 September 2015
- Published by Elsevier in Fertility and Sterility
- Vol. 104 (3) , e20-e21
Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome
- 1 September 2015
- Published by Elsevier in Fertility and Sterility
- Vol. 104 (3) , e20-e21
Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome